Engineering of polymeric nanoparticles for medical applications

Dr Omid Farokhzad - Harvard Medical School, Boston, USA
Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )
14 Nov 2013

Chemosaturation therapy for cancers in the liver

Dr Stephen Fenwick - Aintree University Hospital, Liverpool, UK
Chemosaturation therapy for cancers in the liver ( Dr Stephen Fenwick - Aintree University Hospital, Liverpool, UK )
11 Nov 2013

Percutaneous Hepatic Perfusion: localised chemo for liver cancer

Dr Alex Vahrmeijer - Leiden University Medical Centre, Netherlands
Percutaneous Hepatic Perfusion: localised chemo for liver cancer ( Dr Alex Vahrmeijer - Leiden University Medical Centre, Netherlands )
4 Oct 2013

ecancerNews Highlights from September 2013

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancerNews Highlights from September 2013 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
24 Sep 2013

Does radiotherapy have a place in the adjuvant treatment of pancreatic cancer?

Dr Bernard Cummings - University of Toronto, Toronto, Canada
Does radiotherapy have a place in the adjuvant treatment of pancreatic cancer? ( Dr Bernard Cummings - University of Toronto, Toronto, Canada )
25 Jul 2013

Development and research of vaccines to prevent liver cancer

Dr Pierre Hainaut – International Prevention research Institute, Lyon, France
Development and research of vaccines to prevent liver cancer ( Dr Pierre Hainaut – International Prevention research Institute, Lyon, France )
24 Jul 2013

Molecular stratification identifies exceptional responders to therapy for pancreatic cancer

Dr David Chang – Wolfson Wohl Cancer Research Centre, University of Glasgow, UK
Molecular stratification identifies exceptional responders to therapy for pancreatic cancer ( Dr David Chang – Wolfson Wohl Cancer Research Centre, University of Glasgow, UK )
18 Jul 2013

ECC 2013 Preview: Scientific programme highlights

Prof Vincenzo Valentini and Ian Banks
ECC 2013 Preview: Scientific programme highlights ( Prof Vincenzo Valentini and Ian Banks )
11 Jul 2013

Science behind phase I clinical trials: targeting tumour cell development pathways

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA
Science behind phase I clinical trials: targeting tumour cell development pathways ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )
6 Jun 2013

ASCO 2013 highlights

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA
ASCO 2013 highlights ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )
6 Jun 2013

Next generation of anti-cancer agents: data from ASCO 2013

Dr Sarah Blagden - Imperial College, London, UK
Next generation of anti-cancer agents: data from ASCO 2013 ( Dr Sarah Blagden - Imperial College, London, UK )
4 Jun 2013

10 years experience in pancreatic surgery

Dr Pier Giulianotti - Illinois Medical Center, Chicago, USA
10 years experience in pancreatic surgery  ( Dr Pier Giulianotti - Illinois Medical Center, Chicago, USA )
19 Dec 2012